title: Bordetella petrii sinusitis in an immunocompromised adolescent.
authors.affiliation: Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
authors.forename: Jason M
authors.initials: JM
authors.lastname: Nagata
authors.forename: Gregory W
authors.initials: GW
authors.lastname: Charville
authors.forename: Jenna M
authors.initials: JM
authors.lastname: Klotz
authors.forename: Walter R
authors.initials: WR
authors.lastname: Wickremasinghe
authors.forename: Dylan C
authors.initials: DC
authors.lastname: Kann
authors.forename: Hayden T
authors.initials: HT
authors.lastname: Schwenk
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Longhurst
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001884:Bordetella / Q000302:isolation & purification*; D001885:Bordetella Infections / Q000175:diagnosis* / Q000382:microbiology*; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008443:Maxillary Sinus / Q000382:microbiology / Q000473:pathology; D008826:Microbial Sensitivity Tests; D012852:Sinusitis / Q000175:diagnosis* / Q000382:microbiology*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination